6.
Raez L, Santos E, Rolfo C, Lopes G, Barrios C, Cardona A
. Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America. Clin Lung Cancer. 2016; 18(1):e71-e79.
DOI: 10.1016/j.cllc.2016.05.003.
View
7.
Infante M, Cavuto S, Lutman F, Passera E, Chiarenza M, Chiesa G
. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. Am J Respir Crit Care Med. 2015; 191(10):1166-75.
DOI: 10.1164/rccm.201408-1475OC.
View
8.
Markowitz S, Manowitz A, Miller J, Frederick J, Onyekelu-Eze A, Widman S
. Yield of Low-Dose Computerized Tomography Screening for Lung Cancer in High-Risk Workers: The Case of 7189 US Nuclear Weapons Workers. Am J Public Health. 2018; 108(10):1296-1302.
PMC: 6137787.
DOI: 10.2105/AJPH.2018.304518.
View
9.
Jonas D, Reuland D, Reddy S, Nagle M, Clark S, Weber R
. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021; 325(10):971-987.
DOI: 10.1001/jama.2021.0377.
View
10.
Paci E, Puliti D, Pegna A, Carrozzi L, Picozzi G, Falaschi F
. Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial. Thorax. 2017; 72(9):825-831.
DOI: 10.1136/thoraxjnl-2016-209825.
View
11.
Moberg J, Oxman A, Rosenbaum S, Schunemann H, Guyatt G, Flottorp S
. The GRADE Evidence to Decision (EtD) framework for health system and public health decisions. Health Res Policy Syst. 2018; 16(1):45.
PMC: 5975536.
DOI: 10.1186/s12961-018-0320-2.
View
12.
Castro S, Sosa E, Lozano V, Akhtar A, Love K, Duffels J
. The impact of income and education on lung cancer screening utilization, eligibility, and outcomes: a narrative review of socioeconomic disparities in lung cancer screening. J Thorac Dis. 2021; 13(6):3745-3757.
PMC: 8264678.
DOI: 10.21037/jtd-20-3281.
View
13.
Chansky K, Sculier J, Crowley J, Giroux D, Meerbeeck J, Goldstraw P
. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol. 2009; 4(7):792-801.
DOI: 10.1097/JTO.0b013e3181a7716e.
View
14.
Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P
. Risk factors for lung cancer worldwide. Eur Respir J. 2016; 48(3):889-902.
DOI: 10.1183/13993003.00359-2016.
View
15.
Rodriguez-Rabassa M, Simmons V, Vega A, Moreno D, Irizarry-Ramos J, Quinn G
. Perceptions of and Barriers to Lung Cancer Screening Among Physicians in Puerto Rico: A Qualitative Study. J Health Care Poor Underserved. 2021; 31(2):973-991.
PMC: 7791893.
DOI: 10.1353/hpu.2020.0072.
View
16.
Tammemagi M, Ruparel M, Tremblay A, Myers R, Mayo J, Yee J
. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study. Lancet Oncol. 2021; 23(1):138-148.
PMC: 8716337.
DOI: 10.1016/S1470-2045(21)00590-8.
View
17.
Mattiuzzi C, Lippi G
. Current Cancer Epidemiology. J Epidemiol Glob Health. 2019; 9(4):217-222.
PMC: 7310786.
DOI: 10.2991/jegh.k.191008.001.
View
18.
Maldonado F, Bartholmai B, Swensen S, Midthun D, Decker P, Jett J
. Are airflow obstruction and radiographic evidence of emphysema risk factors for lung cancer? A nested case-control study using quantitative emphysema analysis. Chest. 2010; 138(6):1295-302.
DOI: 10.1378/chest.09-2567.
View
19.
Pinsky P, Kramer B
. Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening. J Natl Cancer Inst. 2015; 107(11).
PMC: 4849359.
DOI: 10.1093/jnci/djv226.
View
20.
Yong P, Sigel K, de-Torres J, Mhango G, Kale M, Kong C
. The effect of radiographic emphysema in assessing lung cancer risk. Thorax. 2019; 74(9):858-864.
DOI: 10.1136/thoraxjnl-2018-212457.
View